% | $
Quotes you view appear here for quick access.

Novavax, Inc. Message Board

  • tony_montello2003 tony_montello2003 Apr 9, 2013 10:01 PM Flag

    H7N9 H2H Nvax: The companys technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles

    China needs to call Nvax now before it's too late, The new H7N9 has evolved to a very deadly virus that mutates 8 times faster than the regular flu and needs to be controlled now and there only one vaccine platform that does this most effectively that's Nvax VLP technology. I truly hope that this gets controlled right away because nobody and I mean nobody is gonna make a penny dead so please no fear mongers that are posting that there should be more deaths. I would like to say that Chinese cooperation with WHO and CDC is unprecedented they know that if this mother mutates to H2H lights out!

    Let it be written,
    Dr. Tony Montello

7.49+0.22(+3.03%)Jul 1 4:00 PMEDT